The Proteasome Inhibitor, MG132, Attenuates Diabetic Nephropathy by Inhibiting SnoN Degradation In Vivo and In Vitro
Transforming growth factor-β (TGF-β) has been shown to be involved in diabetic nephropathy (DN). The SnoN protein can regulate TGF-β signaling through interaction with Smad proteins. Recent studies have shown that SnoN is mainly degraded by the ubiquitin-proteasome pathway. However, the role of SnoN...
Main Authors: | Wei Huang, Chen Yang, Qinling Nan, Chenlin Gao, Hong Feng, Fang Gou, Guo Chen, Zhihong Zhang, Pijun Yan, Juan Peng, Yong Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/684765 |
Similar Items
-
SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.
by: Lirong Liu, et al.
Published: (2017-01-01) -
MG132 Ameliorates Kidney Lesions by Inhibiting the Degradation of Smad7 in Streptozotocin-Induced Diabetic Nephropathy
by: Chenlin Gao, et al.
Published: (2014-01-01) -
SnoN facilitates axonal regeneration after spinal cord injury.
by: Jiun L Do, et al.
Published: (2013-01-01) -
TGF-β Repressors SnoN and Ski Are Implicated in Human Colorectal Carcinogenesis
by: Vasiliki Bravou, et al.
Published: (2009-01-01) -
Proteasome Inhibition in P. falciparum: MG132 as a tool compound and the generation of MG132-tolerant parasites
by: Collins, Joey Marisha
Published: (2015)